Stages:

• Early
• Expansion
• Growth

 

Industries:

Information Technology

Life Sciences & Healthcare

Medical Device

 

Description:

Lilly Ventures is the venture capital arm of Eli Lilly and Company, a leading innovation-driven pharmaceutical company. The fund's primary goal is to facilitate the success of companies in Lilly's areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under management and focuses on three major areas of interest: Biotechnology, targeting investments in biotechnology companies that leverage proprietary drug discovery or development technologies to build a robust pipeline; Healthcare IT, targeting investments in start-up companies with innovative network technologies that promise to have a transformational impact on the current pharmaceutical business model; and Medical Technology, targeting investments in companies focusing on the convergence of pharmaceuticals, devices or diagnostics. The fund also has a sister fund, Lilly Asian Ventures, which was established in 2007, and has a geographic focus on the emerging life science businesses of east and south Asia, particularly China and India.